AeroVironment
AVAV
$117.70
+0.16%
AeroVironment, Inc. is a defense technology provider operating in the Aerospace & Defense industry, delivering integrated capabilities across air, land, sea, space, and cyber domains through two reportable segments: Autonomous Systems (AxS), which houses its uncrewed aircraft, uncrewed underwater vehicles, ground robots, and precision strike systems, and Space, Cyber and Directed Energy (SCDE), which was substantially expanded through the transformative BlueHalo acquisition. The company is best characterized as a high-growth, mid-cap defense disruptor rather than a legacy prime contractor, with a distinct competitive identity built on attritable drone systems such as Switchblade loitering munitions, counter-UAS technologies, and autonomous multi-domain robotics that have become increasingly central to modern military doctrine. The current investor narrative is dominated by the tension between powerful top-line momentum — a record backlog reportedly approaching $1.5-2.7 billion, a $500 million Army counter-drone award, and surging demand tied to Iran-related defense supply gaps — and a deeply unprofitable, cash-consumptive consolidated profile following the debt-and-equity-funded BlueHalo deal, which has left the SCDE segment dilutive and the stock down sharply despite bullish sell-side conviction. Investors are actively debating whether the autonomous-systems growth engine can scale fast enough to justify a premium multiple, or whether integration costs, thin contract-level margins, and a hostile rate-and-oil macro backdrop will keep the shares under pressure.…
AVAV
AeroVironment
$117.70
Related headlines
Investment Opinion: Should I buy AVAV Today?
Rating: Hold. The core thesis is that AeroVironment possesses a strong growth engine in autonomous systems, evidenced by a record $1.5B backlog and a $500M Army contract, but its unprofitable financial profile and integration risks warrant caution. The analyst consensus is Buy (mean 1.70) with an average target of $216.16, implying 77.5% upside, yet the stock's severe underperformance (-67% over one year) reflects deep skepticism about execution.
Supporting evidence includes: 1) Revenue growth of 5.68% YoY in Q1 FY2027, with gross margin expanding to 25.9% from 20.9%; 2) A low debt-to-equity of 0.19 and current ratio of 4.30, providing financial flexibility; 3) A forward P/E of 27.6x and PEG of 0.08, which are attractive if earnings estimates of $7.66 are met; 4) The stock trades at a P/S of 4.84, a premium to the industry average (typically 1-2x for defense), but justified by higher growth. However, the negative net margin (-13.4%) and free cash flow of only $2.19M highlight the lack of profitability.
Key risks include: 1) Continued losses and cash burn, with no clear path to profitability; 2) Integration challenges from BlueHalo, which could delay synergies; 3) Macro headwinds from rising rates and oil prices, which pressure growth valuations. The rating would upgrade to Buy if the company demonstrates sustained positive net income and free cash flow above $50M, or if the stock price falls below $100 (providing a margin of safety). It would downgrade to Sell if revenue growth decelerates below 5% or if backlog fails to convert. Relative to its history, the stock is undervalued (trading at a fraction of its 52-week high), but relative to peers, it is overvalued on current earnings. Thus, the valuation verdict is fairly valued to slightly overvalued on fundamentals, but potentially undervalued if growth materializes.
Sign up to view all
AVAV 12-Month Price Forecast
The forward-looking view is balanced: the company has strong top-line momentum and a robust backlog, but profitability remains elusive. Valuation is attractive on forward earnings, but the market is skeptical due to past losses and integration risks. The stock's high beta and macro headwinds add volatility. I would upgrade to bullish if the company reports positive EPS and free cash flow exceeding $50M in the next two quarters, or if the stock drops below $100 (providing a margin of safety). I would downgrade to bearish if revenue growth falls below 5% or if backlog conversion stalls.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on AeroVironment's 12-month outlook, with a consensus price target around $213.07 and implied upside of +81.0% versus the current price.
Average Target
$213.07
0 analysts
Implied Upside
+81.0%
vs. current price
Analyst Count
—
covering this stock
Price Range
$149 - $315
Analyst target range
Drowning in data?
Find the real signal!
Bulls vs Bears: AVAV Investment Factors
The bear case currently has stronger evidence due to the company's unprofitable profile, severe stock underperformance, and macro headwinds. However, the bull case is supported by record backlog, a $500M Army contract, and an attractive forward valuation if earnings materialize. The single most important tension is whether AeroVironment can convert its robust backlog into sustainable profits and cash flow, thereby justifying its premium multiple. Resolution of this debate will likely determine whether the stock rebounds toward analyst targets or continues to drift lower.
Bullish
- Record backlog and $500M Army award: AeroVironment's backlog reportedly stands at $1.5B (with some sources citing $2.7B), anchored by a $500M Army counter-drone contract announced in July 2026. This provides multi-year revenue visibility and validates the company's leadership in attritable autonomous systems.
- Revenue growth and margin expansion: Q1 FY2027 revenue grew 5.68% YoY to $480.5M, while gross margin expanded to 25.9% from 20.9% a year earlier. The sequential improvement in profitability suggests integration costs are being managed and operating leverage is beginning to materialize.
- Strong balance sheet with low leverage: Debt-to-equity is only 0.19 and the current ratio is a robust 4.30, indicating ample liquidity to fund growth initiatives and absorb BlueHalo integration costs. This financial flexibility is a key differentiator versus highly levered defense peers.
- Analyst consensus remains bullish: All 22 analysts rate the stock a Buy (mean recommendation 1.70), with an average target price of $216.16, implying 77.5% upside from the current $121.79. The high target of $315 suggests significant long-term conviction despite recent price weakness.
Bearish
- Deeply unprofitable with negative margins: The company reported a trailing net margin of -13.4% and operating margin of -3.6%, with a quarterly net loss of $5.1M in Q1 FY2027. The SCDE segment remains dilutive, and the path to sustained profitability is uncertain.
- Severe stock underperformance and technical damage: AVAV has plunged 67.4% over the past year and 52.5% YTD, massively underperforming the S&P 500 (which gained 15.5% and 11.9%, respectively). The stock is down 22.2% in the last month alone, reflecting deteriorating investor confidence.
- Premium valuation despite losses: At a P/S of 4.84 and EV/Sales of 3.25, the stock trades at a premium to many defense peers, yet it lacks profitability. The negative EV/EBITDA of -286.8 and P/CF of -122.1 highlight the disconnect between valuation and current cash generation.
- BlueHalo integration risks and dilution: The transformative BlueHalo acquisition has ballooned the share count to ~49.8M from ~28M, diluting existing shareholders. Integration costs and thin contract-level margins in SCDE could continue to pressure earnings for years.
AVAV Technical Analysis
Beta
1.36
1.36x market volatility
Max Drawdown
-71.3%
Largest decline past year
52-Week Range
$114-$408
Price range past year
Annual Return
-66.9%
Cumulative gain past year
| Period | AVAV Return | S&P 500 |
|---|---|---|
| 1m | -24.6% | -1.2% |
| 3m | -21.3% | +3.4% |
| 6m | -40.0% | +7.0% |
| 1y | -66.9% | +14.4% |
| ytd | -54.1% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
AVAV Fundamental Analysis
Quarterly Revenue
$480490000.0B
2026-08
Revenue YoY Growth
+5.7%
YoY Comparison
Gross Margin
25.9%
Latest Quarter
Free Cash Flow
$2188000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is AVAV Overvalued?
PE
-36.1x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 28x~223x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-286.8x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: AeroVironment's financial profile is strained by persistent losses, with a trailing net margin of -13.4% and operating margin of -3.6%. The company generated only $2.19M in trailing free cash flow, highlighting cash consumption. The BlueHalo acquisition has increased debt and equity, with debt-to-equity at 0.19 (manageable but not insignificant) and share count rising to ~49.8M from ~28M, diluting shareholders. Revenue concentration in the Autonomous Systems segment (majority of revenue) and dependence on government contracts expose the company to budgetary and geopolitical risks.
Market & Competitive Risks: The stock trades at a premium valuation (P/S 4.84, EV/Sales 3.25) despite negative earnings, leaving it vulnerable to multiple compression if growth slows or profitability remains elusive. Competition from larger defense primes and emerging drone manufacturers could pressure margins. Regulatory headwinds, including export controls and defense budget uncertainties, add risk. The macro backdrop of rising oil prices and Treasury yields (as noted in recent news) disproportionately affects high-beta (1.36) growth stocks like AVAV, which has underperformed the S&P 500 by 83% over the past year.
Worst-Case Scenario: A worst-case scenario would involve continued losses, failure to integrate BlueHalo profitably, and a slowdown in defense spending, leading to a re-rating to the 52-week low of $116.43 (only 4.4% below the current price) or the analyst low target of $148.57 (which is above the current price, oddly). However, the stock has already fallen 67% from its 52-week high of $408.25, and the max drawdown is -70.6%. From the current $121.79, a drop to the 52-week low of $116.43 represents a 4.4% downside, but a more severe scenario could see the stock test the $100 level (18% downside) if losses widen and backlog conversion disappoints.
FAQ
The key risks are: 1) Financial: persistent losses (net margin -13.4%) and cash burn, with free cash flow of only $2.19M; 2) Integration: BlueHalo acquisition may not yield expected synergies, and SCDE remains dilutive; 3) Macro: high beta (1.36) and rising rates/oil prices could compress valuation; 4) Competitive: larger defense primes and new entrants could erode market share. The most severe risk is a failure to convert backlog into profits, which could lead to further stock declines.
Our 12-month forecast has three scenarios: Bull (25% probability) targeting $216-$315, Base (50%) targeting $148-$216, and Bear (25%) targeting $100-$148. The base case is most likely, assuming steady revenue growth and margin stability but continued losses. The key assumption is that backlog conversion proceeds without major hiccups. The stock is currently near the bear case range, so any positive surprise could trigger a rally toward the base case.
On traditional metrics, AVAV appears overvalued: P/S of 4.84 and EV/Sales of 3.25 are premium to defense peers, and the company is loss-making. However, on forward earnings, the P/E of 27.6x and PEG of 0.08 suggest undervaluation if consensus EPS of $7.66 is achieved. The market is pricing in significant growth, but skepticism is high given the stock's 67% decline. Relative to its own history, the stock is cheap (trading at a fraction of its 52-week high), but relative to peers, it is expensive on current fundamentals. The valuation implies the market expects a turnaround, but patience is required.
AVAV presents a high-risk, high-reward opportunity. The stock trades at $121.79, down 67% from its 52-week high, with an average analyst target of $216.16 (77.5% upside). However, the company is unprofitable (net margin -13.4%) and has minimal free cash flow, so the upside depends on successful execution. The biggest downside risk is a continued cash burn and failure to integrate BlueHalo, which could push the stock to $100 or lower. For risk-tolerant investors with a long-term view, it could be a good buy on weakness, but conservative investors should wait for profitability.
AVAV is more suitable for long-term investment (minimum 2-3 years) given its growth stage, high volatility (beta 1.36), and lack of dividend. The company's earnings visibility is improving with a $1.5B backlog, but profitability is still years away. Short-term trading is risky due to high volatility and macro sensitivity. Investors should be prepared for drawdowns and have a time horizon that allows for the execution of the growth story.